Drug-Associated Giant Cell Arteritis with Scalp Necrosis After Treatment with Pembrolizumab: a Case Report

2022 ◽  
Vol 4 (1) ◽  
Author(s):  
Bassel Bou Dargham ◽  
Julianna Kang ◽  
Joshua Gavin ◽  
Abhishek Nandan
2009 ◽  
Vol 61 (4) ◽  
pp. 701-706 ◽  
Author(s):  
Athanasios Tsianakas ◽  
Jan M. Ehrchen ◽  
Dagmar Presser ◽  
Tobias Fischer ◽  
Birgit Kruse-Loesler ◽  
...  

2021 ◽  
Author(s):  
Bassel Bou Dargham ◽  
Julianna Kang ◽  
Joshua Gavin ◽  
Nandan Abhishek

Abstract Giant cell arteritis (GCA) can be a rheumatologic complication of checkpoint inhibitor immunotherapy for the treatment of cancer. A rare and serious manifestation of GCA is scalp necrosis. We report a case of a patient who developed GCA and subsequent scalp necrosis after the initiation of immunotherapy with the checkpoint inhibitor pembrolizumab for the treatment of metastatic melanoma. Such advanced cases of GCA may be increasingly recognized in the immunotherapy era of oncology.


2013 ◽  
Vol 4 ◽  
pp. S139
Author(s):  
J. Fonseca ◽  
R. Tenreiro ◽  
J. Espírito-Santo ◽  
C. Canha ◽  
M.A. Castellano ◽  
...  

Author(s):  
Fotis Konstantinou ◽  
Natalia Vallianou ◽  
Victoria Gennimata ◽  
Angelos Konstantinou ◽  
Evangelos Kokkinakis

BDJ ◽  
1997 ◽  
Vol 183 (7) ◽  
pp. 260-262 ◽  
Author(s):  
P P Nixon ◽  
M Payne ◽  
C D Franklin

Sign in / Sign up

Export Citation Format

Share Document